GlassScriptPhysician profile
Juliet Nelson
NPI 1376003160
$1,731.40
in general payments reported to CMS, 2019-2025
23 companies · $261 in 2025
The $261 reported for 2025 was less than what a typical Psychiatric/Mental Health (Nurse Practitioner) provider received nationally (typical 2025 total: $257).
See the full distribution for Psychiatric/Mental Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $710 · 2022: $356 · 2023: $186 · 2024: $218 · 2025: $261.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $665.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $665.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $253.64 | 2022-2025 | Caplyta |
| Abbvie INC. | $217.65 | 2021-2025 | |
| Neos Therapeutics, LP | $157.22 | 2021 | |
| Neurocrine Biosciences, INC. | $144.41 | 2021-2025 | |
| Teva Pharmaceuticals USA, INC. | $111.17 | 2024 | Austedo Xr |
| Biogen, INC. | $107.28 | 2024 | |
| Validus Pharmaceuticals LLC | $97.74 | 2021-2022 | |
| Tris Pharma INC | $81.74 | 2021-2022 | |
| Bausch Health US, LLC | $76.89 | 2021 | |
| Sunovion Pharmaceuticals INC. | $74.36 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $62.97 | 2021-2022 | |
| Lundbeck LLC | $53.28 | 2021-2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $52.60 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $46.98 | 2021 | |
| Supernus Pharmaceuticals, INC. | $45.08 | 2021-2022 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Otsuka America Pharmaceutical, INC. | $39.62 | 2021-2022 | |
| Alkermes, INC. | $20.18 | 2021 | |
| Ironshore Pharmaceuticals INC. | $19.13 | 2022 | |
| Corium, LLC | $16.74 | 2022 | |
| Jazz Pharmaceuticals INC. | $14.07 | 2021 | |
| Eisai INC. | $13.72 | 2021 | |
| Almatica Pharma LLC | $12.86 | 2021 | |
| Merck Sharp & Dohme LLC | $12.07 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Juliet Nelson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.